Search Results for

Showing 1 - 3 of 3 results
  1. Spotlight on members: Spark

    Spotlight on members From hospital funding to FDA approval Spark Therapeutics develops gene therapy for inherited retinal blindness After over two decades of research and development in gene therapy, Katherine A. High, MD, co-founder, president and chief scientific officer of Spark Therapeutics, is breathing a big sigh of relief this fall. On Oct. 12, the Food and Drug Administration unanimously voted to approve voretigene neparvovec, Spark Therapeutics' gene therapy treatment for inherited b

  2. Journals and Publications landing

    Journals and Publications ARVO's Open Access Journals EyeFind The Association for Research in Vision and Ophthalmology (ARVO) and the Eye Bank Association of America (EBAA) recognize a need to improve the exchange of information between scientists and the eye banks that supply human donor eye tissues for their research. Working collaboratively, ARVO members and EBAA members developed an online tool to facilitate better communication. ARVONews ARVO Insight Funding Guide More resources

  3. Travel Documentation

    Information to make your preparation and journey to Baltimore go as smooth as possible